
The design and construction of biopharma manufacturing facilities is a technical, complex and expensive endeavor that continues to evolve in response to innovations in equipment and manufacturing …
Home - NIIMBL
NIIMBL works to enhance innovative manufacturing capabilities and develop a world-leading manufacturing workforce for the biopharmaceutical industry.
Future of biopharma manufacturing | McKinsey
Oct 11, 2022 · What might manufacturing operations look like if biopharma companies adopt digital and analytics at scale? Consider the way digital technology has reshaped the auto industry, transforming …
BioPharma 4.0 Explained: An NSF Guide
Oct 3, 2024 · Biopharma 4.0 is a specialized framework within Pharma 4.0, uniquely tailored to the context of biopharmaceutical manufacturing. It introduces increased connectivity, productivity, and …
BioPharma Manufacturing News | BioPharma Dive
Oct 20, 2025 · The latest news in manufacturing in the biotech and biopharmaceutical industry.
Trends shaping biopharma in 2025 - Deloitte US
Jul 10, 2025 · Some biopharma companies have transitioned to smart manufacturing using cloud computing for efficient drug production, inventory management/cost management, and digital twins …
Pharma Manufacturing - Home | Control Design
Aug 5, 2011 · Pharma Manufacturing provides news, analysis and examples of how leading pharmaceutical companies are tackling drug development, scale-up and manufacturing challenges.
Modulus: Redefining Biopharma Manufacturing - Sanofi
Oct 8, 2025 · Modulus represents a win-win-win innovation in the field of biopharma manufacturing. More than just a factory, it redefines healthcare delivery with flexibility and speed, enabling us to …
Biopharmaceutical Manufacturing: Progress, Trends and ...
This volume “Cell Engineerring 11 - Biopharmaceutical Manufacturing: Progress, Trends and Challenges” is a source of the latest innovative research and technical development in …
North Carolina Biopharmaceutical Manufacturing | North ...
We use the term “ biopharma manufacturing ” to describe the breadth of North Carolina's community. It encompasses biopharmaceutical and small-molecule pharmaceutical manufacturers as well as the …